DDQN-based optimal targeted therapy with reversible inhibitors to combat the Warburg effect

From MaRDI portal
Publication:6178607















This page was built for publication: DDQN-based optimal targeted therapy with reversible inhibitors to combat the Warburg effect

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6178607)